[1] Iwatsuki K, Ohstuka M, Harada H, et al. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproli ferative disorders. Arch Dermatol, 1997,133:1081-1086. [2] Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell, 1986, 47:883-889. [3] Arrand JR. Epstein-Barr virus. In:Arrand JR and Harper DR eds. Virus and human cancer. 1st ed. Oxford:BIOS Scientific Publishers Limited, 1998.65-91. [4] Jaffe ES, Chan JK, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Defi nitions, differential diagnosis, and epidemiology.Am J Surg Pathol, 1996,20:103-111. [5] Perniciaro C, Zalla MJ, White JW Jr, et al.Subcutaneous T-cell lymphoma. Report of two additional cases and further observations.Arch Dermatol, 1993,129:1171-1176. [6] Romero LS, Goltz RW, Nagi C, et al. Subcutaneous T-cell lymphoma with associated hemophagocytic syndrome and terminal leukemic transformation. J Am Acad Dermatol, 1996,34:904-910. [7] Abdel-Hamid M, Chen JJ, Constantine N, et al. EBV strain variation:geographical distribution and relation to disease state. Virology, 1992, 190, 168-175. |